Bryce D. Carmine retired as an executive vice president at Eli Lilly and Co. and president of Lilly Bio-Medicines in 2011. Previously, he was executive vice president, Global Marketing and Sales, with the company. Carmine joined Lilly in 1975 in New Zealand and subsequently held several marketing and management positions in New Zealand and in the U.S. in the early ’80s before becoming general manager of a joint venture pharmaceutical company in South Korea.
He subsequently managed the Lilly operations in Australia and New Zealand before becoming president of Eli Lilly Japan from 1995 to June 1999 when he was named president, Global Product Development. He had several leadership roles throughout his career in industry associations, culminating in his role as the chairman of ISEC and a board member of the European Association, and the European Federal of Pharmaceutical Industries and Associations at the time of his retirement.
Mr. Carmine earned a BS in biochemistry from Massey University in New Zealand.